Skip to content
Clinical Trials – home
Centre Hospitalier Regional Et Universitaire De Brest
Sponsor

Centre Hospitalier Regional Et Universitaire De Brest

France 2 Avenue Marechal Foch, 29200 Brest, France

About the sponsor

Centre Hospitalier Regional Et Universitaire De Brest is involved in research on aortic stenosis, pulmonary embolism, deep vein thrombosis, venous thromboembolism, and pulmonary arterial hypertension. Its studies also address post-procedural cardiac conduction issues and vascular complications linked to thrombotic disease.

  • Transcatheter aortic valve complications
  • Pulmonary vascular remodeling
  • Recurrent venous thrombosis
  • Thrombosis prevention

Additional interests include imaging-based assessment of cardiopulmonary function and the detection of occult malignancy in patients with thromboembolic disease.

About Specializations

Centre Hospitalier Regional Et Universitaire De Brest runs clinical trials in conditions such as Myeloproliferative neoplasm, Pulmonary embolism, Lung neoplasm malignant, Polymyalgia rheumatica, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68Ga)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Thyroidectomy+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Naloxegol Oxalate
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Capsaicin
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68Ga)
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Pulmonary embolism

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:GRAPHITE
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).